Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dressler

Showing results (101-110 of 194) with videos related to

Pageof 20
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
Severe tardive dystonia: treatment with continuous intrathecal baclofen administrationD Dressler, R O Oeljeschläger, E Rüther
Annals of Internal Medicine|June 20, 2012
Update in hospital medicine: evidence published in 2011Steven Deitelzweig, Daniel D Dressler, Brian Harte
European Journal of Neurology|January 19, 2006
Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparationsK Frei, D D Truong, D Dressler
Aktuelle Urologie|March 20, 2009
[Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model]A Schulz, A-M Vestweber, D Dressler
European Journal of Neurology|January 19, 2006
Pharmacology of botulinum toxin: differences between type A preparationsR L Rosales, H Bigalke, D Dressler
Clinical Therapeutics|January 25, 2000
Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mgI Bekersky, D Dressler, Q A Mekki
Journal of Neurology|July 1, 1990
Central motor conduction time to bulbocavernosus muscle: evaluation by magnetic brain stimulation and testing of bulbocavernosus reflexD Dressler, P W Schönle, H Neubauer
Schmerz (Berlin, Germany)|December 4, 2003
[Use of botulinum toxin the the treatment of muscle pain]R Benecke, D Dressler, E Kunesch, et al.
Journal of Clinical Pharmacology|October 12, 1999
Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study designI Bekersky, D Dressler, W Colburn, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 22, 2002
Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's diseaseU Walter, M Wittstock, R Benecke, et al.
Pageof 20

Showing results (101-110 of 194) with videos related to

Sort By:
Pageof 20
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
Severe tardive dystonia: treatment with continuous intrathecal baclofen administrationD Dressler, R O Oeljeschläger, E Rüther
Annals of Internal Medicine|June 20, 2012
Update in hospital medicine: evidence published in 2011Steven Deitelzweig, Daniel D Dressler, Brian Harte
European Journal of Neurology|January 19, 2006
Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparationsK Frei, D D Truong, D Dressler
Aktuelle Urologie|March 20, 2009
[Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model]A Schulz, A-M Vestweber, D Dressler
European Journal of Neurology|January 19, 2006
Pharmacology of botulinum toxin: differences between type A preparationsR L Rosales, H Bigalke, D Dressler
Clinical Therapeutics|January 25, 2000
Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mgI Bekersky, D Dressler, Q A Mekki
Journal of Neurology|July 1, 1990
Central motor conduction time to bulbocavernosus muscle: evaluation by magnetic brain stimulation and testing of bulbocavernosus reflexD Dressler, P W Schönle, H Neubauer
Schmerz (Berlin, Germany)|December 4, 2003
[Use of botulinum toxin the the treatment of muscle pain]R Benecke, D Dressler, E Kunesch, et al.
Journal of Clinical Pharmacology|October 12, 1999
Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study designI Bekersky, D Dressler, W Colburn, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 22, 2002
Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's diseaseU Walter, M Wittstock, R Benecke, et al.
Pageof 20